CKD-501, D745, D150
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Type 2 DiabetesType2 Diabetes Mellitus
Phase 1
A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150
CompletedNCT04334213
Start: 2020-05-07End: 2020-08-05Updated: 2020-10-30
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
CompletedNCT04810676
Start: 2021-04-16End: 2021-05-26Updated: 2021-06-10
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
CompletedNCT07304687
Start: 2025-10-24End: 2025-11-22Updated: 2025-12-26
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
CompletedNCT07304726
Start: 2025-10-30End: 2025-11-23Updated: 2025-12-26